MIR6859-3

Across TCGA pan-cancer cohorts, MIR6859-3 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MIR6859-3 data layer compared with 10 for mass-spec protein.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher MIR6859-3 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6859-3 expression acts as an unfavorable survival marker.

CESC and UCEC are the cancer types where MIR6859-3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Median	All	0.226	0.740	.017	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR6859-3–CESC (DFS)

Open the CESC breakdown →